Despite a lawsuit against the U.S. Fish and Wildlife Service alleging that the agency is breaking laws meant to protect wildlife in the Cape Romain National Wildlife Refuge in South Carolina, a federal court is allowing horseshoe crabs to be harvested while an appeal being is considered.
Charles River Laboratories, a lab supply and contract testing
company, purchases wild-caught horseshoe crabs and drains their
blood, which is then used to produce a product that detects bacteria
in drug and vaccine manufacturing. This product can fetch $60,000 a
gallon, according to Businessinsider.com.
As much as half their volume of blood is collected from the
horseshoe crabs and it’s estimated that 20 percent of harvested
females die after being released. Atlantic horseshoe crabs are
listed as a vulnerable species (one step below endangered) by the
International Union for the Conservation of Nature, and they are an
important part of the ecosystem. Their decline in numbers has also
affected other animals, especially the endangered Red Knot, a bird
which depends heavily on crab eggs to provide energy for its
remarkable 9,000 mile annual migration.
Despite a lawsuit against the U.S. Fish and Wildlife Service
alleging that the agency is breaking laws meant to protect wildlife
in the Cape Romain National Wildlife Refuge in South Carolina, a
federal court is allowing horseshoe crabs to be harvested while an
appeal being is considered.
This animal suffering is not necessary. There are alternatives
accepted for use in the European Union, but the U.S. Food and Drug
Administration has yet to approve their use.